Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
Robotic surgery fuels Johnson & Johnson dividend growth outlook
Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare…